ATLANTA (October 3, 2017)—Mobile telehealth and remote patient monitoring company SynsorMed Inc. has formed a strategic relationship with a leading global manufacturer of oxygen delivery equipment, CAIRE Inc., to provide medical equipment providers with the tools they need to serve their patients suffering from respiratory disease.
TUCSON, Ariz. (July 10, 2017)—COPD hospitalizations are at an all-time high. The 30-day readmission rate for patients ranges from 20 to 39 percent, with related health care costs at an estimated $50 billion. A recently published study, funded by Royal Philips, revealed that although positive airway pressure (PAP) therapy was associated with a reduction in hospitalization, more than 92 percent of patients studied were not receiving it in any form.
AMSTERDAM (May 22, 2017)—Recently published advancements in pulmonary research suggest that the combination of non-invasive ventilation (NIV) and home oxygen therapy (HOT) can significantly prolong time to readmission or death for patients with chronic obstructive pulmonary disease (COPD) following a life-threatening respiratory event or exacerbation.
SAN DIEGO (March 17, 2017)—In recognition of World Sleep Day, ResMed, a provider of sleep disorder diagnosis and treatment, has picked its top five sleep apnea research findings of 2016.
SAN DIEGO (January 4, 2017)—ResMed today announced that it has achieved a new record in digital connected care: One billion nights of sleep data have been downloaded using ResMed's revolutionary remote patient monitoring platform, AirView.
Update: On Wedneday, November 30, 2016, the House passed the measure with sweeping bipartisan support.
AMSTERDAM (November 17, 2016)—On World COPD Day, Royal Philips is proud to announce the Breathe Boldly social initiative, which aims to raise awareness for Chronic Obstructive Pulmonary Disease (COPD). Patients with COPD often have trouble breathing, sometimes feeling as though they are breathing through a straw.
AMSTERDAM (October 25, 2016)—In conjunction with Respiratory Care Week (October 23–29), Royal Philips announced the launch of “COPD insider,” an online community where leaders in value-based Chronic Obstructive Pulmonary Disease (COPD) care will discuss new and innovative solutions, highlight the biggest issues in COPD care, share a wealth of knowledge and provide practical solutions fo
WASHINGTON, D.C. (October 18, 2016)—Dan Starck, chair of CQRC, responds to the GAO Access Report on Competitive Bidding:
"While the CQRC has supported competitive bidding in concept, we remain deeply concerned about the implementation of the competitive bidding program. Today's report shows that fewer beneficiaries are receiving home oxygen therapy in light of competitive bidding."
LONDON and AMSTERDAM (September 7, 2016)—Royal Philips announced preliminary results of an independent, multicenter Home Oxygen Therapy-Home Mechanical Ventilation (HOT-HMV) study carried out by respiratory experts at St Thomas’ Hospital in London. Philips’s work in chronic obstructive pulmonary disease (COPD) started several decades ago when it began providing health care professionals and patients with innovative treatment solutions and services.
SAN DIEGO (September 7, 2016)—ResMed welcomed positive results from a multicenter, randomized controlled trial known as HOT-HMV. The study was presented today during the 2016 European Respiratory Society International Congress in London.
AMSTERDAM (August 29, 2016)—Royal Philips announced its sponsorship of the documentary “COPD: Highly Illogical—Remembering Leonard Nimoy.” The documentary seeks to educate viewers about COPD through Leonard Nimoy’s personal story of courage, while also providing the latest information about treatments for the chronic disease.
WASHINGTON, D.C. (July 6, 2016)—The Council for Quality Respiratory Care (CQRC)—a coalition of the nation’s home oxygen therapy providers and manufacturing companies—commended Congressman Tom Price (R-GA), David Loebsack (D-IA), Cathy McMorris-Rogers (R-WA), Peter Welch (D-VT) and their colleagues in the United States House of Representatives, for passing the Patient Access to Durable Medical Equipment (PADME) Act (H.R.
WASHINGTON, D.C. (June 22, 2016)—The Council for Quality Respiratory Care (CQRC)—a coalition of the nation’s leading home oxygen therapy provider and manufacturing companies—commended Senators John Thune and Heidi Heitkamp, as well as Senate Finance Committee Chairman Orrin Hatch and Ranking Member Ron Wyden, and their colleagues in the U.S.
WASHINGTON, D.C. (May 27, 2016)—The Council for Quality Respiratory Care (CQRC)—a coalition of the nation’s leading home respiratory therapy providers and manufacturing companies—warned that findings released from the Department of Health and Human Services (HHS) Office of the Inspector General (OIG) signal fundamental flaws in the competitive bidding rate setting process for Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS).
WASHINGTON, D.C. (May 18, 2016)—The Council for Quality Respiratory Care (CQRC) today cautioned that data released from the Centers for Medicare & Medicaid Services (CMS) do not fully reflect the true impact of Medicare cuts recently imposed on Durable Medical Equipment, Prosthetics, Orthotics & Supplies (DMEPOS), including home-based respiratory therapies.